Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

Literature DB >> 1889965

Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

T Yamaguchi¹, C Irisawa, H Watanabe, S Kawamura, T Nakada.

Abstract

A 42-year-old woman with pheochromocytoma received preoperatively a combined alpha- and beta-adrenoceptor blocking agent, amosulalol, exerting some inhibitory action on both receptors. Severe hypertension and remarkable fluctuation of heart rate occurred following this medication. Although it is claimed currently that a combined blocking agent is useful for the management of this disease, it should be administered with caution.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1991 PMID： 1889965 DOI： 10.1007/bf02550413

Source DB: PubMed Journal: Int Urol Nephrol ISSN： 0301-1623 Impact factor: 2.370

Keyword Cloud
References

14 in total

1. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].

Authors: H Matsuura; S Koyama; Y Tsuchioka; M Yoshida; H Kurogane
Journal: Horumon To Rinsho Date: 1982-12

2. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.

Authors: T Takenaka; M Asano; A Berdeaux; J F Giudicelli
Journal: Eur J Pharmacol Date: 1982-11-05 Impact factor: 4.432

3. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.

Authors: G Reach; M Thibonnier; C Chevillard; P Corvol; P Milliez
Journal: Br Med J Date: 1980-05-31

4. [Direct evidence of alpha-adrenoceptor binding in rat and human adrenal glands].

Authors: H Furuta
Journal: Nihon Hinyokika Gakkai Zasshi Date: 1990-02

5. Comparison of airway obstruction induced by propranolol and YM-09538 (a combined alpha- and beta-adrenoceptor blocking drug).

Authors: K Tomioka; T Yamada; T Takenaka
Journal: Arch Int Pharmacodyn Ther Date: 1982-03

Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

1. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].

2. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.

3. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.

4. [Direct evidence of alpha-adrenoceptor binding in rat and human adrenal glands].

5. Comparison of airway obstruction induced by propranolol and YM-09538 (a combined alpha- and beta-adrenoceptor blocking drug).

6. Antihypertensive and adrenoceptor blocking properties of new sulfonamide-substituted phenylethylamines.

7. Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients.

8. Pheochromocytoma and prazosin.

9. Advances in the diagnosis and treatment of pheochromocytoma.

10. Pheochromocytoma: current status and changing trends.